At a glance
ClinicalIndex Comparison RecordN/AActive· 280 enrolled
Drug / intervention
GORE VIABAHN VBX Balloon Expandable Endoprosthesisdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Post-Market Registry of the GORE® VIABAHN® VBX Balloon Expandable Endoprosthesis Implanted in Peripheral Vessels
In Brief
An observational study evaluating GORE VIABAHN VBX Balloon Expandable Endoprosthesis for Peripheral Vascular Diseases. Active but no longer recruiting, targeting 280 participants across 11 sites in 5 countries.
Detailed Summary
The primary objective of the VBX 17-04 registry is to collect post-market safety and performance data of the GORE® VIABAHN® VBX Balloon Expandable Endoprosthesis (VBX Stent Graft) in peripheral vessels in patients who require interventional treatment
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsPeripheral Vascular Diseases
CountriesFrance, Germany, Italy, Netherlands, Spain
Collaborators--
Timeline
N/AActive
201920202021202220232024202520262027
First PostedOct 2018
Enrollment StartDec 2018
Primary CompletionApr 2022
TodayJul 2026
Study CompletionJul 2027
First PostedOct 25, 2018
Enrollment StartDec 18, 2018
Primary CompletionApr 13, 2022
Study CompletionJul 1, 2027
TodayJul 2, 2026
Enrollment to primary: 3.3 yearsPosted 7.7 years ago
Interventions
GORE VIABAHN VBX Balloon Expandable Endoprosthesisdevice
GORE VIABAHN VBX Balloon Expandable Endoprosthesis will be implanted in peripheral vessels in patients who require interventional treatment.